PURPOSE: The relationship between overall obesity and breast cancer risk has been well recognized, but the role of central obesity in breast cancer development is uncertain. METHODS: Between 1998 and 2009, 1,233 invasive breast cancer cases and 1,101 community controls were recruited into the Nigerian Breast Cancer Study at Ibadan, Nigeria. Logistic regressions were used to calculate multivariate odds ratio (OR) and 95% confidence intervals (CI), adjusting for age, body mass index (BMI), and other known risk factors for breast cancer. RESULTS: The OR for the highest quartile group of waist circumference relative to the lowest was 2.39 (95% CI, 1.59-3.60; P-trend < 0.001). Comparing women with waist/hip ratio (WHR) in the lowest quartile group, the OR for women in the highest quartile category was 2.15 (95% CI, 1.61-2.85; P-trend < 0.001). An inverse association was observed between hip circumference and breast cancer, with an OR of 0.36 for the highest quartile (95% CI, 0.24-0.55; P-trend < 0.001). The effects of these three measures existed in both pre- and postmenopausal women. Of note, we found a significant interaction between WHR and BMI (P-interaction = 0.016): the OR comparing the highest to the lowest WHR quartile was 2.81 (95% CI, 1.90-4.16) for women with BMI < 25 kg/m2 and 1.70 (95% CI, 1.11-2.61) for women with BMI ≥ 25 kg/m2. CONCLUSIONS: These results suggest that central adiposity, measured by waist circumference and waist/hip ratio, was an important risk factor for breast cancer in Nigerian women, and the effect of central adiposity was strong in normal-weight women.
PURPOSE: The relationship between overall obesity and breast cancer risk has been well recognized, but the role of central obesity in breast cancer development is uncertain. METHODS: Between 1998 and 2009, 1,233 invasive breast cancer cases and 1,101 community controls were recruited into the Nigerian Breast Cancer Study at Ibadan, Nigeria. Logistic regressions were used to calculate multivariate odds ratio (OR) and 95% confidence intervals (CI), adjusting for age, body mass index (BMI), and other known risk factors for breast cancer. RESULTS: The OR for the highest quartile group of waist circumference relative to the lowest was 2.39 (95% CI, 1.59-3.60; P-trend < 0.001). Comparing women with waist/hip ratio (WHR) in the lowest quartile group, the OR for women in the highest quartile category was 2.15 (95% CI, 1.61-2.85; P-trend < 0.001). An inverse association was observed between hip circumference and breast cancer, with an OR of 0.36 for the highest quartile (95% CI, 0.24-0.55; P-trend < 0.001). The effects of these three measures existed in both pre- and postmenopausal women. Of note, we found a significant interaction between WHR and BMI (P-interaction = 0.016): the OR comparing the highest to the lowest WHR quartile was 2.81 (95% CI, 1.90-4.16) for women with BMI < 25 kg/m2 and 1.70 (95% CI, 1.11-2.61) for women with BMI ≥ 25 kg/m2. CONCLUSIONS: These results suggest that central adiposity, measured by waist circumference and waist/hip ratio, was an important risk factor for breast cancer in Nigerian women, and the effect of central adiposity was strong in normal-weight women.
Authors: D Max Parkin; Freddy Sitas; Mike Chirenje; Lara Stein; Raymond Abratt; Henry Wabinga Journal: Lancet Oncol Date: 2008-07 Impact factor: 41.316
Authors: X O Shu; F Jin; Q Dai; J R Shi; J D Potter; L A Brinton; J R Hebert; Z Ruan; Y T Gao; W Zheng Journal: Int J Cancer Date: 2001-11-01 Impact factor: 7.396
Authors: G Fagherazzi; N Chabbert-Buffet; A Fabre; G Guillas; M-C Boutron-Ruault; S Mesrine; F Clavel-Chapelon Journal: Int J Obes (Lond) Date: 2011-03-22 Impact factor: 5.095
Authors: P Muti; M Stanulla; A Micheli; V Krogh; J L Freudenheim; J Yang; H J Schünemann; M Trevisan; F Berrino Journal: Cancer Causes Control Date: 2000-09 Impact factor: 2.506
Authors: D Huo; C A Adebamowo; T O Ogundiran; E E Akang; O Campbell; A Adenipekun; S Cummings; J Fackenthal; F Ademuyiwa; H Ahsan; O I Olopade Journal: Br J Cancer Date: 2008-02-26 Impact factor: 7.640
Authors: Louise A Brinton; Jonine D Figueroa; Baffour Awuah; Joel Yarney; Seth Wiafe; Shannon N Wood; Daniel Ansong; Kofi Nyarko; Beatrice Wiafe-Addai; Joe Nat Clegg-Lamptey Journal: Breast Cancer Res Treat Date: 2014-03-07 Impact factor: 4.872
Authors: Louise A Brinton; Baffour Awuah; Joe Nat Clegg-Lamptey; Beatrice Wiafe-Addai; Daniel Ansong; Kofi M Nyarko; Seth Wiafe; Joel Yarney; Richard Biritwum; Michelle Brotzman; Andrew A Adjei; Ernest Adjei; Francis Aitpillah; Lawrence Edusei; Florence Dedey; Sarah J Nyante; Joseph Oppong; Ernest Osei-Bonsu; Nicholas Titiloye; Verna Vanderpuye; Emma Brew Abaidoo; Bernard Arhin; Isaac Boakye; Margaret Frempong; Naomi Ohene Oti; Victoria Okyne; Jonine D Figueroa Journal: Int J Cancer Date: 2017-03-28 Impact factor: 7.396
Authors: Kimberly A Bertrand; Traci N Bethea; Lucile L Adams-Campbell; Lynn Rosenberg; Julie R Palmer Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-10-18 Impact factor: 4.254